Indaptus Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Indaptus Therapeutics, Inc. has filed 338 SEC EDGAR filings since 20 Apr 2021

SEC filing history

Showing 251-275 of 338 matching filings.

Per page
25
Current page
11
10-Q File 001-40652

10-Q filing

Filing date
12 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
AW File 333-230016

AW filing

Filing date
25 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-259771

EFFECT filing

Filing date
23 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-259771

POS AM filing

Filing date
22 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-230016

POS AM filing

Filing date
21 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-40652

10-K filing

Filing date
21 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2022
Reporting date
25 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92776

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Jan 2022
Reporting date
26 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Jan 2022
Reporting date
26 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Jan 2022
Reporting date
26 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Dec 2021
Reporting date
01 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Dec 2021
Reporting date
29 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-230016

EFFECT filing

Filing date
01 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-230016

POS AM filing

Filing date
30 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Nov 2021
Reporting date
18 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .